InvestorsHub Logo
Followers 689
Posts 143817
Boards Moderated 35
Alias Born 03/10/2004

Re: None

Friday, 04/30/2021 5:22:44 PM

Friday, April 30, 2021 5:22:44 PM

Post# of 617
Earnings Previews: CVS
By: 24/7 Wall St. | April 30, 2021

CVS

Pharmacy and health plan services giant CVS Health Corp. (NYSE: CVS) is scheduled to report quarterly earnings before Tuesday’s opening bell. Shares dropped more than 5% last year, largely as a result of stay-at-home orders and lockdowns. Shares have risen more than 13% so far this year, yielding a 16-month share price gain of around 7.5%.

Most brokerages (15 of 24) rate CVS stock as a Buy or Strong Buy, with a 12-month consensus price target of $87.25. At about $76.35 per share, the upside potential on the stock about 14.3%. At the high target of $102, upside potential is nearly 34%.

Analysts have forecast first-quarter EPS of $1.71, down about 10.5% compared with the year-ago quarter. Revenue is expected to increase by 2.4% to $68.39 billion. For the full year, analysts are looking for EPS of $7.51 on sales of $280.09 billion. In 2020, CVS reported EPS of $7.50 and sales of $268.71 billion.

CVS stock trades at 10.1 times expected 2021 EPS, 9.4 times estimated 2022 earnings and 8.7 times estimated 2023 earnings. The stock’s 52-week range is $55.36 to $77.44, and CVS pays an annual dividend of $2.00 per share (yield of 2.62%).

Read Full Story »»»

DiscoverGold

Information posted to this board is not meant to suggest any specific action, but to point out the technical signs that can help our readers make their own specific decisions. Caveat emptor!
• DiscoverGold

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVS News